Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stakel VTP in Neovascular AMD
NCT01021956Phase 2Terminated
- Sponsor
- Steba Biotech
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of padeliporfin in neovascular age-related macular degeneration (NVAMD), sponsored by Steba Biotech. Started Jun 2010; status: terminated.
02
Drugs
padeliporfin
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT01021956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021956.